ArticlePharmaceuticals (Basel, Switzerland)2022

Dose-Dependent Von Willebrand Factor Inhibition by Aptamer BB-031 Correlates with Thrombolysis in a Microfluidic Model of Arterial Occlusion.

Susan M Shea et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.